Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT2A1 UGT2B4 UGT2B10 UGT2B11	1.41e-04	35	152	4	GO:0015020
GeneOntologyMolecularFunction	ABC-type bile acid transporter activity	ABCC4 ABCB11	3.42e-04	4	152	2	GO:0015432
GeneOntologyMolecularFunction	ATPase-coupled organic acid transmembrane transporter activity	ABCC4 ABCB11	3.42e-04	4	152	2	GO:0033283
GeneOntologyMolecularFunction	ATPase-coupled monocarboxylic acid transmembrane transporter activity	ABCC4 ABCB11	3.42e-04	4	152	2	GO:0033285
GeneOntologyMolecularFunction	ATPase-coupled carboxylic acid transmembrane transporter activity	ABCC4 ABCB11	3.42e-04	4	152	2	GO:0033284
GeneOntologyMolecularFunction	4 iron, 4 sulfur cluster binding	NTHL1 NDUFS2 CDKAL1 SDHB	4.46e-04	47	152	4	GO:0051539
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT2A1 UGT2B4 UGT2B10 UGT2B11	1.50e-05	21	151	4	GO:0052695
GeneOntologyBiologicalProcess	biphenyl catabolic process	UGT2B4 UGT2B10 UGT2B11	2.10e-05	8	151	3	GO:0070980
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT2A1 UGT2B4 UGT2B10 UGT2B11	3.64e-05	26	151	4	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT2A1 UGT2B4 UGT2B10 UGT2B11	3.64e-05	26	151	4	GO:0006063
GeneOntologyBiologicalProcess	biphenyl metabolic process	UGT2B4 UGT2B10 UGT2B11	4.44e-05	10	151	3	GO:0018879
GeneOntologyBiologicalProcess	mitotic DNA replication maintenance of fidelity	RAD51 BRCA2	5.32e-05	2	151	2	GO:1990505
GeneOntologyBiologicalProcess	mitotic recombination-dependent replication fork processing	RAD51 BRCA2	5.32e-05	2	151	2	GO:1990426
GeneOntologyBiologicalProcess	cell cycle DNA replication maintenance of fidelity	RAD51 BRCA2	5.32e-05	2	151	2	GO:1902298
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT2B4 UGT2B10 UGT2B11	8.06e-05	12	151	3	GO:0052697
GeneOntologyBiologicalProcess	cellular response to purine-containing compound	TRPM2 RYR2 TMEM38A	1.32e-04	14	151	3	GO:0071415
GeneOntologyBiologicalProcess	xenobiotic catabolic process	CYP2D6 UGT2B4 UGT2B10 UGT2B11	1.51e-04	37	151	4	GO:0042178
GeneOntologyBiologicalProcess	protein polymerization	BIN1 NCKAP1 MAP2 GSN CRACD DIAPH1 FHDC1 TPPP3 INPP5J HSP90AA1	1.81e-04	334	151	10	GO:0051258
GeneOntologyCellularComponent	growth cone membrane	LAMP5 DCC EXOC7	3.13e-05	9	153	3	GO:0032584
GeneOntologyCellularComponent	proteasome storage granule	PSMD1 PSMD2	5.32e-05	2	153	2	GO:0034515
GeneOntologyCellularComponent	ruffle	JCAD NCKAP1 MAP2 GSN DIAPH1 MACF1 ACAP2 INPP5J	1.42e-04	206	153	8	GO:0001726
GeneOntologyCellularComponent	nuclear outer membrane	GUCY2D UGT2B4 UGT2B10 UGT2B11	2.05e-04	40	153	4	GO:0005640
GeneOntologyCellularComponent	distal axon	BIN1 SLC4A8 MAP2 LAMP5 DCC SLC6A3 DOCK7 EXOC7 CDH8 INPP5J HSP90AA1	3.70e-04	435	153	11	GO:0150034
Domain	DUF3398	DOCK11 DOCK9 DOCK7	9.98e-06	6	150	3	PF11878
Domain	DOCK_C/D_N	DOCK11 DOCK9 DOCK7	9.98e-06	6	150	3	IPR021816
Domain	UDPGT	UGT2A1 UGT2B4 UGT2B10 UGT2B11	2.15e-05	21	150	4	PF00201
Domain	UDPGT	UGT2A1 UGT2B4 UGT2B10 UGT2B11	2.15e-05	21	150	4	PS00375
Domain	UDP_glucos_trans	UGT2A1 UGT2B4 UGT2B10 UGT2B11	2.15e-05	21	150	4	IPR002213
Domain	DHR-1_domain	DOCK11 DOCK9 DOCK7	7.99e-05	11	150	3	IPR027007
Domain	DHR_2	DOCK11 DOCK9 DOCK7	7.99e-05	11	150	3	PS51651
Domain	DHR_1	DOCK11 DOCK9 DOCK7	7.99e-05	11	150	3	PS51650
Domain	DHR-2	DOCK11 DOCK9 DOCK7	7.99e-05	11	150	3	PF06920
Domain	DOCK	DOCK11 DOCK9 DOCK7	7.99e-05	11	150	3	IPR026791
Domain	DOCK_C	DOCK11 DOCK9 DOCK7	7.99e-05	11	150	3	IPR010703
Domain	DOCK-C2	DOCK11 DOCK9 DOCK7	7.99e-05	11	150	3	PF14429
Domain	DHR-2	DOCK11 DOCK9 DOCK7	7.99e-05	11	150	3	IPR027357
Domain	PC_rep	PSMD1 PSMD2	1.91e-04	3	150	2	PF01851
Domain	Proteasome/cyclosome_rpt	PSMD1 PSMD2	1.91e-04	3	150	2	IPR002015
Domain	BAR	BIN1 ARHGAP10 ACAP2	4.48e-04	19	150	3	PS51021
Pathway	WP_GLUCURONIDATION	PGM3 UGT2A1 UGT2B4 UGT2B10 UGT2B11	1.42e-06	25	113	5	MM15820
Pathway	WP_GLUCURONIDATION	PGM3 UGT2A1 UGT2B4 UGT2B10 UGT2B11	1.74e-06	26	113	5	M39404
Pathway	REACTOME_ASPIRIN_ADME	CYP2D6 UGT2A1 UGT2B4 UGT2B10 UGT2B11	2.56e-05	44	113	5	M45014
Pathway	REACTOME_DRUG_ADME	ABCC4 CYP2D6 UGT2A1 UGT2B4 UGT2B10 UGT2B11 PCK1	2.68e-05	109	113	7	M45012
Pathway	REACTOME_ASPIRIN_ADME	CYP2D6 UGT2A1 UGT2B4 UGT2B10 UGT2B11	2.86e-05	45	113	5	MM15694
Pathway	REACTOME_GLUCURONIDATION	UGT2A1 UGT2B4 UGT2B10 UGT2B11	3.67e-05	24	113	4	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT2A1 UGT2B4 UGT2B10 UGT2B11	4.35e-05	25	113	4	M17787
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT2A1 UGT2B4 UGT2B10 UGT2B11	4.35e-05	25	113	4	M605
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT2A1 UGT2B4 UGT2B10 UGT2B11	6.91e-05	28	113	4	M19580
Pathway	REACTOME_PARACETAMOL_ADME	ABCC4 UGT2B4 UGT2B10 UGT2B11	2.59e-04	39	113	4	MM15695
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	CYP2D6 UGT2A1 UGT2B4 UGT2B10 UGT2B11	2.76e-04	72	113	5	M9257
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT2A1 UGT2B4 UGT2B10 UGT2B11	3.15e-04	41	113	4	M7399
Pathway	REACTOME_DRUG_ADME	ABCC4 CYP2D6 UGT2A1 UGT2B4 UGT2B10 UGT2B11	3.86e-04	119	113	6	MM15692
Pathway	PID_P73PATHWAY	RAD51 BIN1 NDUFS2 BRCA2 IL4R	4.26e-04	79	113	5	M19
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	JCAD DLG5 KIAA0930 SASH1 NCKAP1 MAP2 DOCK11 CEP162 HNRNPUL1 RFX7 MELK ZCCHC14 ALMS1 DOCK7 OSBPL6 MACF1 CRYBG3 SIPA1L2 CDC25B WNK3 NOS1AP	3.41e-10	861	156	21	36931259
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	JCAD BIN1 KCNH7 SLC4A8 GOPC NCKAP1 ACADS MAP2 DOCK9 PSMD1 PSMD2 CPZ NDUFS2 RYR2 CSE1L DOCK7 MACF1 CRYBG3 SIPA1L2 SDHB HSP90AA1 NOS1AP	9.12e-09	1139	156	22	36417873
Pubmed	cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.	UGT2B4 UGT2B10 UGT2B11	8.85e-08	3	156	3	8333863
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	KIAA0930 GOPC NCKAP1 ARHGAP10 RBL1 CNOT10 HNRNPUL1 MELK NDUFS2 PGM3 GSN WDR19 CSE1L CNOT6L AP2A1 KCTD3 DOCK7 OSBPL6 TMEM231 EXOC7 CDC25B ACAP2	1.23e-07	1321	156	22	27173435
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF536 TES GOPC ARHGAP10 RBL1 ASCC1 IDH3B CDKAL1 KAT2B ALMS1 RNPS1 SLC25A13 CHD5 DIAPH1 MACF1 CRYBG3 SIPA1L2 TOPORS ZNF687 NOS1AP	1.53e-07	1116	156	20	31753913
Pubmed	M phase-specific phosphorylation of BRCA2 by Polo-like kinase 1 correlates with the dissociation of the BRCA2-P/CAF complex.	RAD51 KAT2B BRCA2	3.53e-07	4	156	3	12815053
Pubmed	MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity.	ZNF536 NTHL1 IDH3B CDKAL1 NOP14 CSE1L AP2A1 KCTD3	4.20e-07	150	156	8	22678362
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	GOPC ARHGAP10 PSMD1 PSMD2 EYA1 PPL CDKAL1 PGM3 GSN CSE1L AP2A1 KCTD3 TMEM131L AKAP10 SIPA1L2 CDC25B SDHB HSP90AA4P	4.31e-07	974	156	18	28675297
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	ASCC1 PSMD1 PSMD2 UFL1 PIGG HNRNPUL1 IDH3B GTPBP10 NDUFS2 CDKAL1 PGM3 GSN CRACD LIG3 JUNB CSE1L CNOT6L SLC25A13 DOCK7 EXOC7 SDHB HSP90AA1	5.30e-07	1440	156	22	30833792
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	BIN1 SASH1 NCKAP1 ACADS MAP2 PSMD2 NDUFS2 GSN AP2A1 BRCA2 SLC25A13 GNAO1 SDHB HSP90AA1	9.01e-07	621	156	14	22794259
Pubmed	PTEN identified as important risk factor of chronic obstructive pulmonary disease.	RAD51 ABCC4 CYP2D6 SLC6A3 LIG3 PARP4 BRCA2 ABCB11 CDC25B IL4R ALOX12	1.11e-06	374	156	11	19625176
Pubmed	Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.	RAD51 ABCC4 CYP2D6 SLC6A3 LIG3 PARP4 BRCA2 ABCB11 CDC25B IL4R ALOX12	1.33e-06	381	156	11	18676680
Pubmed	Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.	RAD51 ABCC4 CYP2D6 SLC6A3 LIG3 PARP4 BRCA2 ABCB11 CDC25B IL4R ALOX12	1.37e-06	382	156	11	19170196
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B4 UGT2B10 UGT2B11	3.06e-06	7	156	3	26074487
Pubmed	Genetic susceptibility to distinct bladder cancer subphenotypes.	RAD51 ABCC4 CYP2D6 SLC6A3 LIG3 PARP4 BRCA2 ABCB11 CDC25B IL4R ALOX12	3.48e-06	421	156	11	19692168
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	DLG5 NCKAP1 ARHGAP10 RGS19 CNOT10 NTHL1 ASCC1 UFL1 PIGG TTF1 GTPBP10 NDUFS2 CRACD JUNB NOP14 CNOT6L ZBED6 SLC25A13 KCTD3 MACF1 ZNF687	3.76e-06	1497	156	21	31527615
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	RAD51 RBL1 LIG3 BRCA2 GUCY2D ABCB11 ZNF624 AKAP10 IL4R ALOX12	4.59e-06	351	156	10	20453000
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B4 UGT2B10 UGT2B11	4.88e-06	8	156	3	32093886
Pubmed	Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.	UGT2A1 UGT2B4 UGT2B10	4.88e-06	8	156	3	10748067
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	NCKAP1 PSMD1 PSMD2 UFL1 HNRNPUL1 PGM3 GSN CSE1L PDIA5 WNK3 HSP90AA1	6.67e-06	451	156	11	36168627
Pubmed	Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.	RAD51 BRCA2 HSP90AA1	7.29e-06	9	156	3	24085845
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	DLG5 CNOT10 CEP162 LIG3 KAT2B ALMS1 AP2A1 RNPS1 DOCK7 DIAPH1 GNAO1 ACAP2 ZNF687	7.52e-06	645	156	13	25281560
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	NCKAP1 CNOT10 PSMD1 PSMD2 IDH3B NDUFS2 PGM3 CSE1L AP2A1 SLC25A13 DIAPH1 EXOC7	9.30e-06	560	156	12	35241646
Pubmed	ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia.	PSMD1 PSMD2 HNRNPUL1 PGM3 CSE1L EXOC7 HSP90AA1	1.07e-05	166	156	7	35687106
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RAD51 DLG5 ASCC1 PSMD1 PSMD2 HNRNPUL1 IDH3B RFX7 PPM1B LIG3 CSE1L AP2A1 RNPS1 SLC25A13 DIAPH1 TOPORS SDHB HSP90AA1	1.34e-05	1247	156	18	27684187
Pubmed	Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.	TES GOPC PSMD2 HNRNPUL1 PPL GSN CSE1L AP2A1 DIAPH1 MACF1 HSP90AA1	1.39e-05	488	156	11	31324722
Pubmed	TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair.	RAD51 BRCA2 TOPORS	1.42e-05	11	156	3	35061896
Pubmed	CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway.	NCKAP1 PPL GSN KCTD3 HSP90AA1	1.87e-05	72	156	5	36123327
Pubmed	DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169.	JCAD CNOT10 HNRNPUL1 RFX7 AP2A1 SIPA1L2	1.95e-05	122	156	6	30773093
Pubmed	Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors.	ABCC4 ABCB11	2.00e-05	2	156	2	25735837
Pubmed	Congenital mirror movements: mutational analysis of RAD51 and DCC in 26 cases.	RAD51 DCC	2.00e-05	2	156	2	24808016
Pubmed	Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma.	RAD51 BRCA2	2.00e-05	2	156	2	34978208
Pubmed	Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51.	RAD51 BRCA2	2.00e-05	2	156	2	9523196
Pubmed	Interrogation of the protein-protein interactions between human BRCA2 BRC repeats and RAD51 reveals atomistic determinants of affinity.	RAD51 BRCA2	2.00e-05	2	156	2	21789034
Pubmed	Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms.	RAD51 BRCA2	2.00e-05	2	156	2	21670257
Pubmed	Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G(2)/M checkpoint control.	RAD51 BRCA2	2.00e-05	2	156	2	10551859
Pubmed	Nascent DNA synthesis during homologous recombination is synergistically promoted by the rad51 recombinase and DNA homology.	RAD51 BRCA2	2.00e-05	2	156	2	24583581
Pubmed	BRCA2-dependent and independent formation of RAD51 nuclear foci.	RAD51 BRCA2	2.00e-05	2	156	2	12606939
Pubmed	Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus.	RAD51 BRCA2	2.00e-05	2	156	2	28067217
Pubmed	BRCA2 BRC motifs bind RAD51-DNA filaments.	RAD51 BRCA2	2.00e-05	2	156	2	15937124
Pubmed	Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.	RAD51 BRCA2	2.00e-05	2	156	2	18632222
Pubmed	Structure of human BRCA2-RAD51 by molecular docking study.	RAD51 BRCA2	2.00e-05	2	156	2	17549502
Pubmed	DNA Strand Exchange to Monitor Human RAD51-Mediated Strand Invasion and Pairing.	RAD51 BRCA2	2.00e-05	2	156	2	32840775
Pubmed	Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations.	RAD51 BRCA2	2.00e-05	2	156	2	31575654
Pubmed	TRIC-A Channel Maintains Store Calcium Handling by Interacting With Type 2 Ryanodine Receptor in Cardiac Muscle.	RYR2 TMEM38A	2.00e-05	2	156	2	31805819
Pubmed	The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.	RAD51 BRCA2	2.00e-05	2	156	2	9560268
Pubmed	Inhibition of filament formation of human Rad51 protein by a small peptide derived from the BRC-motif of the BRCA2 protein.	RAD51 BRCA2	2.00e-05	2	156	2	18429819
Pubmed	Finding significance: New perspectives in variant classification of the RAD51 regulators, BRCA2 and beyond.	RAD51 BRCA2	2.00e-05	2	156	2	37651978
Pubmed	Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation.	MELK CDC25B	2.00e-05	2	156	2	12400006
Pubmed	PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism.	PSMD1 PSMD2	2.00e-05	2	156	2	31703613
Pubmed	Recombination mediator and Rad51 targeting activities of a human BRCA2 polypeptide.	RAD51 BRCA2	2.00e-05	2	156	2	16513631
Pubmed	Polymorphisms of the BRCA2 and RAD51 genes in breast cancer.	RAD51 BRCA2	2.00e-05	2	156	2	16261408
Pubmed	Expression and localization of Na-driven Cl-HCO(3)(-) exchanger (SLC4A8) in rodent CNS.	SLC4A8 MAP2	2.00e-05	2	156	2	18359573
Pubmed	Valine 1532 of human BRC repeat 4 plays an important role in the interaction between BRCA2 and RAD51.	RAD51 BRCA2	2.00e-05	2	156	2	21601571
Pubmed	Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats.	RAD51 BRCA2	2.00e-05	2	156	2	17515903
Pubmed	Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2.	RAD51 BRCA2	2.00e-05	2	156	2	17515904
Pubmed	Disruption of mitochondrial complex I induces progressive parkinsonism.	NDUFS2 SLC6A3	2.00e-05	2	156	2	34732887
Pubmed	Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase.	RAD51 BRCA2	2.00e-05	2	156	2	19875419
Pubmed	Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice.	RAD51 BRCA2	2.00e-05	2	156	2	12619154
Pubmed	Structure-activity relationship of the peptide binding-motif mediating the BRCA2:RAD51 protein-protein interaction.	RAD51 BRCA2	2.00e-05	2	156	2	26992456
Pubmed	BRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells.	RAD51 BRCA2	2.00e-05	2	156	2	25488918
Pubmed	Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor.	RAD51 BRCA2	2.00e-05	2	156	2	25282148
Pubmed	Resistance to therapy caused by intragenic deletion in BRCA2.	RAD51 BRCA2	2.00e-05	2	156	2	18264088
Pubmed	Novel Mutations in Two Saudi Patients with Congenital Retinal Dystrophy.	ALMS1 GUCY2D	2.00e-05	2	156	2	26957854
Pubmed	Structural basis for stabilisation of the RAD51 nucleoprotein filament by BRCA2.	RAD51 BRCA2	2.00e-05	2	156	2	37919288
Pubmed	[Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers].	RAD51 BRCA2	2.00e-05	2	156	2	19253839
Pubmed	Conformational flexibility and oligomerization of BRCA2 regions induced by RAD51 interaction.	RAD51 BRCA2	2.00e-05	2	156	2	32785644
Pubmed	Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.	RAD51 BRCA2	2.00e-05	2	156	2	12442171
Pubmed	A second DNA binding site in human BRCA2 promotes homologous recombination.	RAD51 BRCA2	2.00e-05	2	156	2	27628236
Pubmed	Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction.	RAD51 BRCA2	2.00e-05	2	156	2	23935068
Pubmed	hCAS/CSE1L regulates RAD51 distribution and focus formation for homologous recombinational repair.	RAD51 CSE1L	2.00e-05	2	156	2	26123175
Pubmed	CDC25B phosphorylated by pEg3 localizes to the centrosome and the spindle poles at mitosis.	MELK CDC25B	2.00e-05	2	156	2	15908796
Pubmed	BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents.	RAD51 BRCA2	2.00e-05	2	156	2	35409418
Pubmed	Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2.	RAD51 BRCA2	2.00e-05	2	156	2	14580352
Pubmed	The Tumor-Associated Variant RAD51 G151D Induces a Hyper-Recombination Phenotype.	RAD51 BRCA2	2.00e-05	2	156	2	27513445
Pubmed	Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.	RAD51 BRCA2	2.00e-05	2	156	2	11239456
Pubmed	Congenital mirror movements: phenotypes associated with DCC and RAD51 mutations.	RAD51 DCC	2.00e-05	2	156	2	25813273
Pubmed	Full-length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2.	RAD51 BRCA2	2.00e-05	2	156	2	12941707
Pubmed	The BRC repeats of human BRCA2 differentially regulate RAD51 binding on single- versus double-stranded DNA to stimulate strand exchange.	RAD51 BRCA2	2.00e-05	2	156	2	19628690
Pubmed	Association of diabetes-related variants in ADCY5 and CDKAL1 with neonatal insulin, C-peptide, and birth weight.	ADCY5 CDKAL1	2.00e-05	2	156	2	34169461
Pubmed	The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51.	RAD51 BRCA2	2.00e-05	2	156	2	19303847
Pubmed	Recovery of deficient homologous recombination in Brca2-depleted mouse cells by wild-type Rad51 expression.	RAD51 BRCA2	2.00e-05	2	156	2	18992372
Pubmed	RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2.	RAD51 BRCA2	2.00e-05	2	156	2	9405383
Pubmed	Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA.	RAD51 BRCA2	2.00e-05	2	156	2	20729859
Pubmed	The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA.	RAD51 BRCA2	2.00e-05	2	156	2	20729858
Pubmed	Association of somatic mutations in BRCA2 BRC domain with chemotherapy sensitivity and survival in high grade serous ovarian cancer.	RAD51 BRCA2	2.00e-05	2	156	2	34302857
Pubmed	Rad51 overexpression rescues radiation resistance in BRCA2-defective cancer cells.	RAD51 BRCA2	2.00e-05	2	156	2	18618591
Pubmed	A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange.	RAD51 BRCA2	2.00e-05	2	156	2	16914443
Pubmed	Defining the membrane proteome of NK cells.	ABCC4 CNOT10 DOCK9 PSMD1 PSMD2 PIGG MELK CDKAL1 PARP4 NOP14 CSE1L AP2A1 CHD5 EXOC7 ACAP2 RPL3L HSP90AA1	2.13e-05	1168	156	17	19946888
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	DLG5 TES CDKAL1 ALMS1 TMEM131L MACF1 CRYBG3 SIPA1L2	2.66e-05	263	156	8	34702444
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	NMRAL1 PSMD1 PSMD2 LAMP5 DCC PPL RYR2 NOP14 AP2A1 PHF20L1 RNPS1 SLC25A13 CHD5 MACF1 GNAO1 SIPA1L2 RPL3L PCK1 HSP90AA1	2.69e-05	1442	156	19	35575683
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZNF536 BIN1 TES GOPC MELK CDKAL1 ZCCHC14 CNOT6L ALMS1 DIAPH1 TMEM131L EXOC7 ZNF687	2.87e-05	733	156	13	34672954
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	BIN1 MAP2 DOCK9 PSMD1 PSMD2 ADCY5 AP2A1 MACF1 SIPA1L2	2.91e-05	347	156	9	17114649
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DLG5 ZSCAN12 SASH1 CEP162 UFL1 MELK WDR19 CHD5 TMEM131L ACAP2 ZNF687	2.91e-05	529	156	11	14621295
Pubmed	NOVA2-mediated RNA regulation is required for axonal pathfinding during development.	NTNG1 DCC EPHA5	3.11e-05	14	156	3	27223325
Pubmed	Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.	DOCK11 DOCK9 DOCK7	3.11e-05	14	156	3	12432077
Pubmed	The loss of PGAM5 suppresses the mitochondrial degeneration caused by inactivation of PINK1 in Drosophila.	PSMD1 PSMD2 HSP90AA1	3.11e-05	14	156	3	21151955
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	DLG5 MAP2 UFL1 HNRNPUL1 NDUFS2 LIG3 NOP14 CSE1L AP2A1 SLC25A13 KCTD3 DOCK7 PDIA5 MACF1 SIPA1L2 HSP90AA1	3.12e-05	1082	156	16	38697112
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	JCAD KIAA0930 NCKAP1 DOCK11 CNOT10 CEP162 ALMS1 AP2A1 DOCK7 SIPA1L2	3.61e-05	446	156	10	24255178
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	BIN1 PDE6C MAP2 PSMD2 HNRNPUL1 NDUFS2 GSN CSE1L GUCY2D GNAO1 HSP90AA1	4.28e-05	552	156	11	36293380
Interaction	YWHAH interactions	JCAD DLG5 KIAA0930 SASH1 NCKAP1 MAP2 DOCK11 CEP162 DOCK9 PSMD2 HNRNPUL1 RFX7 MELK LNP1 ZCCHC14 ALMS1 DOCK7 OSBPL6 MACF1 CRYBG3 SIPA1L2 CDC25B WNK3 HSP90AA1 NOS1AP	8.55e-07	1102	153	25	int:YWHAH
Interaction	YWHAQ interactions	JCAD DLG5 KIAA0930 PDE6C SASH1 NCKAP1 MAP2 DOCK11 ARHGAP10 CEP162 PSMD1 UFL1 HNRNPUL1 RFX7 MELK LNP1 CSE1L DOCK7 OSBPL6 MACF1 SIPA1L2 CDC25B PCK1 HSP90AA1	3.79e-06	1118	153	24	int:YWHAQ
Interaction	SYNE3 interactions	JCAD DLG5 CNOT10 NMRAL1 UFL1 CDKAL1 ZCCHC14 ALMS1 BRCA2 TMEM131L PDIA5 MACF1 CRYBG3 SIPA1L2	7.64e-06	444	153	14	int:SYNE3
Interaction	YWHAG interactions	JCAD DLG5 KIAA0930 SASH1 NCKAP1 MAP2 DOCK11 CEP162 DOCK9 PSMD1 HNRNPUL1 RFX7 MELK LNP1 CRACD CSE1L ALMS1 RNPS1 DOCK7 OSBPL6 MACF1 SIPA1L2 CDC25B HSP90AA1 NOS1AP	7.79e-06	1248	153	25	int:YWHAG
Interaction	YWHAZ interactions	JCAD DLG5 KIAA0930 BIN1 PDE6C SASH1 NCKAP1 MAP2 DOCK11 CEP162 DOCK9 UFL1 HNRNPUL1 IDH3B MELK GSN LNP1 CRACD ANKRD34B DOCK7 OSBPL6 MACF1 SIPA1L2 CDC25B HSP90AA1	2.00e-05	1319	153	25	int:YWHAZ
Interaction	YWHAB interactions	DLG5 KIAA0930 BIN1 PDE6C SASH1 NCKAP1 MAP2 DOCK11 CEP162 DOCK9 HNRNPUL1 RFX7 MELK LNP1 RNPS1 DOCK7 OSBPL6 MACF1 SIPA1L2 CDC25B HSP90AA1	2.78e-05	1014	153	21	int:YWHAB
Cytoband	16p13.3	NTHL1 NMRAL1 PPL RNPS1 ZNF75A RPL3L	1.98e-04	244	156	6	16p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr4q13	UGT2A1 UGT2B4 UGT2B10 UGT2B11 EPHA5	2.09e-04	157	156	5	chr4q13
GeneFamily	UDP glucuronosyltransferases	UGT2A1 UGT2B4 UGT2B10 UGT2B11	3.54e-05	32	106	4	363
GeneFamily	EF-hand domain containing\|Plakins	PPL MACF1	9.32e-04	8	106	2	939
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3	DDR1 NDST1 ZNF536 SLC4A8 MAP2 DCC TTF1 GNPDA2 TMEM38A GNAO1 BMPER TPPP3 SEMA4A SIPA1L2 CDC25B CDH8 EPHA5	1.65e-05	730	150	17	Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	ZSCAN12 SLC4A8 RBL1 SKA2 UFL1 TTF1 CDKAL1 CRACD CSE1L CNOT6L ALMS1 BRCA2 CCBE1 SLC25A13 DOCK7 TMEM131L ZNF624 MACF1 GNAO1 SNAPC3 TOPORS WNK3 HSP90AA1	2.50e-05	1257	150	23	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4	SLC4A8 NTNG1 TMEM38A ZNF624 BMPER TPPP3 SEMA4A CDH8 EPHA5	3.05e-05	223	150	9	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	ZNF536 ZSCAN12 SLC4A8 MAP2 RBL1 SKA2 UFL1 TTF1 CDKAL1 CRACD CSE1L CNOT6L ALMS1 BRCA2 CCBE1 SLC25A13 DOCK7 TMEM131L ZNF624 MACF1 GNAO1 SNAPC3 TOPORS WNK3 HSP90AA1	3.19e-05	1459	150	25	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4	DDR1 NDST1 ZNF536 SLC4A8 MAP2 DCC TTF1 GNPDA2 TMEM38A GNAO1 BMPER SEMA4A SIPA1L2 CDC25B CDH8 EPHA5	5.28e-05	721	150	16	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5	DDR1 NDST1 ZNF536 SLC4A8 MAP2 NTNG1 DCC TTF1 GNPDA2 TMEM38A BMPER SEMA4A SIPA1L2 CDC25B CDH8 EPHA5	5.37e-05	722	150	16	Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2	DDR1 NDST1 ZNF536 SLC4A8 MAP2 NTNG1 DCC TTF1 GNPDA2 TMEM38A BMPER SEMA4A SIPA1L2 CDC25B CDH8 EPHA5	8.01e-05	747	150	16	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2	NTNG1 TMEM38A TPPP3 SEMA4A CDH8 EPHA5	9.15e-05	103	150	6	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ZNF536 SLC4A8 MAP2 DCC TTF1 WDR19 ALMS1 TMEM38A BMPER SEMA4A SIPA1L2 CDC25B CDH8 NOS1AP EPHA5	1.11e-04	688	150	15	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	ZNF536 WDR19 ALMS1 TMEM38A MACF1 SEMA4A CDH8 NOS1AP EPHA5	1.36e-04	271	150	9	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_500	ABCC4 BHLHE40 PPL SEMA4A ALOX12	1.38e-04	70	150	5	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2	ZNF536 SLC4A8 MAP2 DCC CRACD TMEM38A MACF1 BMPER TPPP3 SEMA4A SIPA1L2 CDC25B CDH8 EPHA5	2.47e-04	659	150	14	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DNAH3 ZNF536 KCNH7 DCC RYR2 XIRP2 CDH8 EPHA5	9.03e-08	159	155	8	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RAD51 DRC7 NEK10 DSN1 BRCA2 GNPDA2 FHDC1 SNAPC3	1.26e-07	166	155	8	f4698fd08965936d51695d571bd10fb77330d916
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	RAD51 DRC7 NEK10 MELK DSN1 BRCA2 GNPDA2 FHDC1	1.65e-07	172	155	8	e9b97f37bb1732ad9aa89c5e9b513d14022801ac
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 MAP2 DOCK11 LAMP5 ADCY5 SLC6A3 SIPA1L2 ALPK2	3.26e-07	188	155	8	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 MAP2 DOCK11 LAMP5 ADCY5 SLC6A3 SIPA1L2 ALPK2	3.26e-07	188	155	8	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR1 ZNF536 KIAA0930 BIN1 NMRAL1 GSN KCTD3 TPPP3	5.02e-07	199	155	8	67d8c7e5356f5d409d4f98e8338cf6c499fd7aee
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NTNG1 CDKL4 LAMP5 BHLHE40 ANKRD34B DEPDC7 CDH8	6.15e-07	140	155	7	7cc891d676555609add6fc7880735d948a2ad801
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	ZNF536 MAP2 DOCK11 ARHGAP10 ADCY5 SIPA1L2 ALPK2	2.44e-06	172	155	7	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	facs-Lung-EPCAM-3m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TES DOCK11 TMEM131L SEMA4A SNAPC3 STX11 ALPK2	2.95e-06	177	155	7	d445167dae956e641386f84ab3ae9f47c089e09a
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MELK ALMS1 BRCA2 FAM227A TPPP3 TMEM231 CCDC180	3.18e-06	179	155	7	d15182c668d7c37be8214cad9f1fe35d1409c9a1
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MELK ALMS1 BRCA2 FAM227A TPPP3 TMEM231 CCDC180	3.18e-06	179	155	7	e22a275a7c0ed19113c833a75d6c49fcc19aa13a
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DRC7 NEK10 LRRC53 FAM227A TPPP3 TMEM231 CCDC180	3.30e-06	180	155	7	92fb01b91261b3103454924cde56add337b41844
ToppCell	RV\|World / Chamber and Cluster_Paper	NEK10 EYA1 ADCY5 XIRP2 CCBE1 BMPER RPL3L	3.42e-06	181	155	7	bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 MAP2 DOCK11 ARHGAP10 LAMP5 SLC6A3 SIPA1L2	3.42e-06	181	155	7	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 MAP2 DOCK11 ARHGAP10 LAMP5 SLC6A3 SIPA1L2	3.42e-06	181	155	7	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DRC7 DNAH3 NEK10 EYA1 FAM227A TPPP3 TMEM231	3.81e-06	184	155	7	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DRC7 DNAH3 NEK10 EYA1 FAM227A TPPP3 TMEM231	3.95e-06	185	155	7	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DRC7 DNAH3 NEK10 EYA1 FAM227A TPPP3 TMEM231	4.39e-06	188	155	7	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 DNAH3 CDKL4 OSBPL6 FAM47E TPPP3 CCDC180	4.55e-06	189	155	7	02c6128a9ab5818e0881dcadafdad5f08b9a67cf
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 DNAH3 CDKL4 OSBPL6 FAM47E TPPP3 CCDC180	4.55e-06	189	155	7	164ea92ff6a1aa2ead1c9b8f64f99a9d65437232
ToppCell	Epithelial-D_(Ciliated)\|World / shred on cell class and cell subclass (v4)	DRC7 DNAH3 ASCC1 OSBPL6 FAM47E TPPP3 CCDC180	4.55e-06	189	155	7	0bf560b595c7a8450a46bc821b742b67965bd9f9
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 DNAH3 CDKL4 OSBPL6 FAM47E TPPP3 CCDC180	4.55e-06	189	155	7	a85099bd598a27ee64ee0664d051d89fa8d62fc9
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MXRA5 KCNH7 DOCK11 NTNG1 LAMP5 RYR2 CDH8	4.87e-06	191	155	7	156b467187331ac6ca390d6ca861d9670bb7b956
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DRC7 DNAH3 NEK10 EYA1 FAM227A TPPP3 TMEM231	4.87e-06	191	155	7	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DRC7 DNAH3 NEK10 EYA1 FAM227A TPPP3 TMEM231	4.87e-06	191	155	7	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC4 DOCK11 SLC6A3 LNP1 PARP4 UGT2B11 ALPK2	5.40e-06	194	155	7	8ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NTNG1 CDKL4 LAMP5 BHLHE40 GSN DEPDC7	5.56e-06	127	155	6	fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DRC7 DNAH3 NEK10 FAM227A TPPP3 TMEM231 CCDC180	5.77e-06	196	155	7	686a5a0ddb00929842c1c98445c59edfcc9a8a04
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DRC7 DNAH3 NEK10 FAM227A TPPP3 TMEM231 CCDC180	5.77e-06	196	155	7	67aefc480714e4b8c9ae53c036efdc07ec6f94af
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DRC7 DNAH3 NEK10 FAM227A TPPP3 TMEM231 CCDC180	5.77e-06	196	155	7	ca56311edc6788e032e7635fa69b1e07035202b5
ToppCell	Severe_COVID-19-Epithelial-Ciliated\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DRC7 DNAH3 NEK10 FAM227A TPPP3 TMEM231 CCDC180	5.77e-06	196	155	7	1cdef976a754c90d18b6149d367bd64e6e99b0a9
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DRC7 DNAH3 NEK10 FAM227A TPPP3 TMEM231 CCDC180	5.77e-06	196	155	7	69f5081e06d84ec1d9695762df801a9d0df1984b
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR1 ZNF536 KIAA0930 BIN1 NMRAL1 GSN TPPP3	6.17e-06	198	155	7	a183afe4c2034323f77abfa080f359d67da35e8f
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR1 ZNF536 KIAA0930 BIN1 NMRAL1 GSN TPPP3	6.17e-06	198	155	7	27f0654fb0857e93f030e1a4b1c307b31576bbcd
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR1 ZNF536 KIAA0930 BIN1 NMRAL1 GSN TPPP3	6.17e-06	198	155	7	fef9a4c96450078527b94d25e681410e4ea01b13
ToppCell	(11)_FOXN4+\|World / shred by cell type by condition	CEP162 MELK ALMS1 BRCA2 FAM227A TPPP3 TMEM231	6.17e-06	198	155	7	516b1acdf997dd8debc3dca066519366e507b414
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDR1 DNAH3 NEK10 UGT2A1 FAM227A TPPP3 TMEM231	6.17e-06	198	155	7	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DRC7 DNAH3 NEK10 UGT2A1 FAM227A TMEM231 CCDC180	6.59e-06	200	155	7	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDR1 ABCC4 EYA1 PDIA5 WNK3 NOS1AP	7.25e-06	133	155	6	5bf5e654653e2c340891f51e3f2a30441b7b6b2b
ToppCell	droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DDR1 SLC4A8 RFX7 TMEM38A PCK1 NOS1AP	8.24e-06	136	155	6	a43b3db1754c619d328a26a2ba6af4756629a723
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NTNG1 CDKL4 LAMP5 BHLHE40 LNP1 ANKRD34B	1.01e-05	141	155	6	40ef6d792e11fe10963d64eb0b606b90556c1a70
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DRC7 NTNG1 CDKL4 LAMP5 BHLHE40 ANKRD34B	1.14e-05	144	155	6	08005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DRC7 DNAH3 NEK10 UGT2A1 FAM227A CCDC180	1.67e-05	154	155	6	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DRC7 DNAH3 NEK10 UGT2A1 FAM227A CCDC180	1.67e-05	154	155	6	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RGSL1 SERPINA12 SLC6A3 ABCB11 TPPP3 EPHA5	2.23e-05	162	155	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Ciliated_cells-B-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	DRC7 NEK10 OSBPL6 UGT2B4 FAM227A TMEM231	2.56e-05	166	155	6	4b1056aad8a99827835242b8ab0c7f2bb84471f1
ToppCell	droplet-Lung-LUNG-30m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR1 SLC4A8 BHLHE40 MELK ALMS1 PCK1	2.73e-05	168	155	6	0e8b0e6399c6c82c9c0e546f7316f902de0765d3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BIN1 DOCK9 RASGEF1A IDH3B GNPDA2 IL4R	2.83e-05	169	155	6	01a24a8817628125bd004b2be68ffa62c7111f6e
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIWIL4 CPZ CCBE1 SEMA4A NOS1AP EPHA5	2.92e-05	170	155	6	417b77c12a7982b1ce4b4bc57f30335d261220f5
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 DLG5 ABCC4 ZSCAN12 FHDC1 FAM47E	3.22e-05	173	155	6	ef8d720b99470fe1953661f6e66bc0366266bdb6
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 ABCC4 MXRA5 ARHGAP10 BMPER CRYBG3	3.33e-05	174	155	6	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	Ciliated_cells-A-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	ZNF536 KCNH7 NEK10 EYA1 OSBPL6 FAM227A	3.55e-05	176	155	6	1c364155f46b9a7c995bdc2cc2333c437cd90f5b
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPUL1 RYR2 GSN XIRP2 ZBED6 MACF1	3.55e-05	176	155	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SASH1 DOCK11 ARHGAP10 EYA1 CDKAL1 PARP4	3.55e-05	176	155	6	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NTNG1 BHLHE40 ANKRD34B CCBE1 ABCB11 CRYBG3	3.66e-05	177	155	6	a25ca82c4bda033ee113f8ecb4a541b22e7a29ca
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 NTNG1 RYR2 CCBE1 BMPER DEPDC7	3.66e-05	177	155	6	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 ARHGAP10 EYA1 NIPAL3 CDKAL1 PARP4	3.66e-05	177	155	6	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NTNG1 BHLHE40 ANKRD34B CCBE1 ABCB11 CRYBG3	3.66e-05	177	155	6	fbead6e56271b1f1d447f89857de444ebe7157b0
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 NTNG1 RYR2 CCBE1 BMPER DEPDC7	3.66e-05	177	155	6	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_MORN2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NTNG1 BHLHE40 ANKRD34B CCBE1 ABCB11 CRYBG3	3.78e-05	178	155	6	b0fc56f583cb3f2977fe2306994c0d478c9a6b1b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 NTNG1 CRACD MGAT5 CCBE1 TPPP3	3.90e-05	179	155	6	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC4 BIN1 DOCK11 DCC ANKRD34B ALPK2	3.90e-05	179	155	6	58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	JCAD SASH1 BHLHE40 MACF1 SIPA1L2 IL4R	4.02e-05	180	155	6	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRC7 JCAD ZSCAN12 SLC4A8 SLC25A13 CHD5	4.02e-05	180	155	6	7368ab31c3273374ef260f0d710d4eea83cbc4a2
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTNG1 CRACD MGAT5 XIRP2 CCBE1 TPPP3	4.15e-05	181	155	6	5bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTNG1 CRACD MGAT5 XIRP2 CCBE1 TPPP3	4.15e-05	181	155	6	8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCell	LA-04._Ventricular_Cardiomyocyte_I\|LA / Chamber and Cluster_Paper	KAT2B XIRP2 UGT2B4 FHDC1 DEPDC7	4.16e-05	110	155	5	34dcd1e1e16e8b6088ff9a7a40532e8bd000c121
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SKA2 CCBE1 SLC25A13 SEMA4A CDC25B KLHDC4	4.28e-05	182	155	6	21dcab170ffeef89faa9fee5008568cb6e15c694
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	DRC7 DNAH3 NEK10 EYA1 FAM227A TPPP3	4.28e-05	182	155	6	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	DRC7 DNAH3 NEK10 EYA1 FAM227A TMEM231	4.28e-05	182	155	6	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 SASH1 DOCK11 CRACD ANKRD34B INPP5J	4.28e-05	182	155	6	a3c5c0eff527c8d3848acda14af8f9e99c69b0de
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DRC7 NTNG1 CDKL4 LAMP5 BHLHE40	4.34e-05	111	155	5	1847dde68d349114286bc3317be6339666df4aa2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 MAP2 NTNG1 CRACD CCBE1 TPPP3	4.41e-05	183	155	6	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 NTNG1 CRACD MGAT5 CCBE1 TPPP3	4.41e-05	183	155	6	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RGSL1 PIWIL4 PPL CCDC180 NOS1AP	4.53e-05	112	155	5	456278fb92dd41820fde8cf27c68fec45e15f972
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC4 SASH1 DOCK11 EYA1 PPL PARP4	4.55e-05	184	155	6	da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 DNAH3 CDKL4 FAM47E TPPP3 CCDC180	4.55e-05	184	155	6	797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADCY5 RYR2 XIRP2 UGT2B4 RPL3L ALPK2	4.55e-05	184	155	6	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 DNAH3 CDKL4 FAM47E TPPP3 CCDC180	4.55e-05	184	155	6	77d5b60a20b277f589b18f7a131142a7ef2dac17
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 MAP2 LAMP5 SLC6A3 SIPA1L2 ALPK2	4.69e-05	185	155	6	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	DRC7 DNAH3 NEK10 EYA1 FAM227A TMEM231	4.69e-05	185	155	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RAD51 SKA2 MELK SLC6A3 BRCA2 CDC25B	4.69e-05	185	155	6	9d424a8608b339dd6129c58d87626678d4ec4af7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 MAP2 LAMP5 SLC6A3 SIPA1L2 ALPK2	4.69e-05	185	155	6	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH7 RASGEF1A LAMP5 RYR2 CHD5 NOS1AP	4.83e-05	186	155	6	7278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCell	PND28-Epithelial-Epithelial_Airway\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 OSBPL6 FAM47E TPPP3 CCDC180 HSP90AA1	4.97e-05	187	155	6	f777dd5eb5ccd554ebe1ed60a738b5dd45e18bb9
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	NTNG1 DCC RYR2 CCBE1 MACF1 BMPER	4.97e-05	187	155	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH7 RASGEF1A RYR2 CNOT6L CHD5 NOS1AP	4.97e-05	187	155	6	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH7 RASGEF1A RYR2 CNOT6L CHD5 NOS1AP	4.97e-05	187	155	6	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	ZNF536 ARHGAP10 RYR2 CRACD CCBE1 BMPER	4.97e-05	187	155	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	NEK10 EYA1 ADCY5 XIRP2 RPL3L ALPK2	4.97e-05	187	155	6	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH7 RASGEF1A RYR2 CNOT6L CHD5 NOS1AP	4.97e-05	187	155	6	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	Epithelial-Epithelial-D_(Ciliated)\|Epithelial / shred on cell class and cell subclass (v4)	DNAH3 ASCC1 FAM47E TPPP3 CCDC180 HSP90AA1	5.12e-05	188	155	6	8f30535a32968a81a304315a49c0d90a77d36948
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	DRC7 DNAH3 NEK10 EYA1 FAM227A TPPP3	5.12e-05	188	155	6	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SASH1 DOCK11 EYA1 PPL CDKAL1 PARP4	5.12e-05	188	155	6	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 DNAH3 CDKL4 FAM47E TPPP3 CCDC180	5.28e-05	189	155	6	b55de812043b670cbde810d7d42f45909b6d66ef
ToppCell	PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 OSBPL6 FAM47E TPPP3 CCDC180 HSP90AA1	5.28e-05	189	155	6	fa1ff8b7fa53f3148d9117d6e598097f03af5eb2
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DRC7 DNAH3 NEK10 EYA1 FAM227A TPPP3	5.28e-05	189	155	6	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DRC7 DNAH3 NEK10 EYA1 FAM227A TMEM231	5.28e-05	189	155	6	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	PND10-Epithelial-Epithelial_Airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 DNAH3 OSBPL6 FAM47E TPPP3 CCDC180	5.28e-05	189	155	6	407d8a59969d83f014600aae1a55092283a13970
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC4 DOCK11 EYA1 PPL CDKAL1 PARP4	5.28e-05	189	155	6	904b8337e2cabac2f0bf5dad5598fc429581ed81
Drug	Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A	BIN1 PDE6C ARHGAP10 CEP162 BHLHE40 CDKAL1 RYR2 DIAPH1 SEMA4A EXOC7 INPP5J	1.14e-07	196	156	11	4403_DN
Drug	menthol	TRPM2 UGT2A1 UGT2B4 UGT2B10 UGT2B11 CDH8 ALPK2	2.29e-06	87	156	7	CID000001254
Drug	l-borneol	EYA1 UGT2A1 UGT2B4 UGT2B10 UGT2B11	5.17e-06	37	156	5	CID000010049
Drug	C1 11-32	UGT2A1 UGT2B4 UGT2B10 UGT2B11	6.02e-06	18	156	4	CID000443077
Drug	C11131	UGT2A1 UGT2B4 UGT2B10 UGT2B11	6.02e-06	18	156	4	CID000443076
Drug	T4-G	UGT2A1 UGT2B4 UGT2B10 UGT2B11	7.59e-06	19	156	4	CID000152424
Drug	harmol	ABCC4 UGT2A1 UGT2B4 UGT2B10 UGT2B11	7.68e-06	40	156	5	CID000068094
Drug	Conessine [546-06-5]; Up 200; 11.2uM; PC3; HT_HG-U133A	ACADS MAP2 CEP162 DOCK9 NTNG1 PPL SNAPC3 RPL3L INPP5J	8.67e-06	196	156	9	4191_UP
Drug	6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; MCF7; HT_HG-U133A	NDST1 DLG5 RBL1 CDKAL1 ALMS1 BRCA2 DIAPH1 SNAPC3 TMEM231	8.67e-06	196	156	9	7346_DN
Drug	testosterone glucuronide	TES UGT2A1 UGT2B4 UGT2B10 UGT2B11	8.70e-06	41	156	5	CID000108192
Drug	fluconazole	KCNH7 CYP2D6 CPZ UGT2A1 UGT2B4 UGT2B10 UGT2B11	9.10e-06	107	156	7	CID000003365
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	BIN1 CDKAL1 RYR2 PGM3 KAT2B CSE1L ALMS1 DIAPH1 ZFYVE26	9.41e-06	198	156	9	7442_DN
Drug	androsterone glucuronide	GOPC UGT2A1 UGT2B4 UGT2B10 UGT2B11	1.10e-05	43	156	5	CID000114833
Drug	estriol-16-glucuronide	UGT2A1 UGT2B4 UGT2B10 UGT2B11	1.16e-05	21	156	4	CID000122281
Drug	AC1N8H7N	ABCC4 UGT2A1 UGT2B4 UGT2B10 ABCB11 UGT2B11	1.61e-05	78	156	6	CID004318740
Drug	estradiol-3-glucuronide	UGT2A1 UGT2B4 UGT2B10 UGT2B11	1.70e-05	23	156	4	CID000066651
Drug	L-idaro-1,4-lactone	UGT2A1 UGT2B4 UGT2B10 UGT2B11	3.82e-05	28	156	4	CID000078997
Drug	13-HODE	RAD51 RBL1 BHLHE40 UGT2B4 UGT2B10 ALOX12 PCK1	4.32e-05	136	156	7	CID000001424
Drug	7-hydroxycoumarin glucuronide	UGT2A1 UGT2B4 UGT2B10 UGT2B11	4.41e-05	29	156	4	CID000125641
Drug	acetaminophen glucuronide	ABCC4 UGT2A1 UGT2B4 UGT2B10 UGT2B11	5.26e-05	59	156	5	CID000083944
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A	DLG5 BIN1 SASH1 WDR19 JUNB PHF20L1 AKAP10 SEMA4A	5.95e-05	194	156	8	5696_DN
Drug	2 E1	CYP2D6 GOPC UGT2A1 UGT2B4 UGT2B10 ABCB11 UGT2B11	6.49e-05	145	156	7	CID006102788
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	NDST1 DNAH3 ABCC4 CEP162 CDKAL1 CSE1L EXOC7 IL4R	6.63e-05	197	156	8	6271_UP
Drug	DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A	RAD51 TES SLC4A8 NCKAP1 ACADS CEP162 PHF20L1 ZFYVE26	6.63e-05	197	156	8	7543_DN
Drug	AC1Q6OQG	UGT2A1 UGT2B4 UGT2B10 UGT2B11	7.43e-05	33	156	4	CID000009686
Drug	BP-3,6-quinol	UGT2A1 UGT2B4 UGT2B10 UGT2B11	7.43e-05	33	156	4	CID000119292
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	UGT2B4 UGT2B10 UGT2B11	1.10e-05	9	152	3	EFO_0600040
Disease	alkaline phosphatase measurement	DLG5 SLC4A8 ARHGAP10 NTNG1 BHLHE40 ADCY5 PPL GSN MGAT5 UGT2B4 ABCB11 FAM227A MACF1 FAM47E UGT2B11 PCK1 ALPK2	2.03e-05	1015	152	17	EFO_0004533
Disease	protein disulfide-isomerase A5 measurement	ADCY5 PDIA5	2.64e-05	2	152	2	EFO_0801941
Disease	serum gamma-glutamyl transferase measurement	JCAD DLG5 SLC4A8 ACADS DOCK11 ARHGAP10 NTNG1 RYR2 KAT2B UGT2B4 UGT2B10 ABCB11 FAM227A SIPA1L2 ALPK2	8.03e-05	914	152	15	EFO_0004532
Disease	Disorder of eye	BEST1 PDE6C IDH3B ALMS1 GUCY2D SEMA4A TOPORS	1.20e-04	212	152	7	C0015397
Disease	congenital mirror movement disorder (is_implicated_in)	RAD51 DCC	1.57e-04	4	152	2	DOID:0111153 (is_implicated_in)
Disease	Bipolar Disorder	ACADS MAP2 DOCK9 TRPM2 NTNG1 BHLHE40 SLC6A3 BRCA2 AKAP10 ALOX12	1.93e-04	477	152	10	C0005586
Disease	Retinitis Pigmentosa	BEST1 IDH3B GUCY2D SEMA4A TOPORS	2.07e-04	104	152	5	C0035334
Disease	type 2 diabetes mellitus (implicated_via_orthology)	SERPINA12 CDKAL1 ALMS1 PCK1 SDHB	2.17e-04	105	152	5	DOID:9352 (implicated_via_orthology)
Disease	Mood Disorders	CYP2D6 MAP2 SLC6A3 KAT2B RNPS1 HSP90AA1	2.43e-04	168	152	6	C0525045
Disease	cancer (implicated_via_orthology)	RBL1 PGM3 BRCA2 MACF1 ACAP2 HSP90AA1 HSP90AA4P	4.98e-04	268	152	7	DOID:162 (implicated_via_orthology)
Disease	vanillylmandelate (VMA) measurement	UGT2B4 UGT2B10	5.44e-04	7	152	2	EFO_0800119
Disease	Retinitis pigmentosa	BEST1 IDH3B SEMA4A TOPORS	5.89e-04	74	152	4	cv:C0035334
Disease	Squamous cell carcinoma of lung	DDR1 WNK3 EPHA5	5.96e-04	32	152	3	C0149782
Disease	cystic fibrosis (implicated_via_orthology)	ABCC4 ABCB11	9.27e-04	9	152	2	DOID:1485 (implicated_via_orthology)
Disease	heart disease (implicated_via_orthology)	RYR2 KAT2B CNOT6L	9.91e-04	38	152	3	DOID:114 (implicated_via_orthology)
Disease	Parkinson Disease	CYP2D6 MAP2 TRPM2 SLC6A3	9.91e-04	85	152	4	C0030567
Disease	Colorectal Carcinoma	DNAH3 ABCC4 MAP2 NTHL1 NTNG1 DCC LIG3 CSE1L CHD5 ABCB11 ZNF624	1.07e-03	702	152	11	C0009402
Disease	early infantile epileptic encephalopathy (implicated_via_orthology)	IDH3B GNAO1	1.41e-03	11	152	2	DOID:0050709 (implicated_via_orthology)
Disease	C-reactive protein measurement	ZNF536 BIN1 TES ACADS ARHGAP10 SKA2 ADCY5 PPL OR2B11 DOCK7 ABCB11 FAM227A MACF1 GNAO1 IL4R	1.46e-03	1206	152	15	EFO_0004458
Disease	cholesteryl ester 20:5 measurement	JCAD BEST1 CDKAL1	1.52e-03	44	152	3	EFO_0010349
Disease	Gastrointestinal Stromal Sarcoma	NDST1 TMEM231 SDHB	1.84e-03	47	152	3	C3179349
Disease	X-19141 measurement	UGT2B4 UGT2B11	1.98e-03	13	152	2	EFO_0800799
Disease	Schizophrenia	DDR1 CYP2D6 NTNG1 DCC BHLHE40 GSN SLC6A3 GNAO1 ALOX12 PCK1 WNK3 NOS1AP	2.13e-03	883	152	12	C0036341
Disease	insomnia measurement	ZNF536 MAP2 ARHGAP10 TRPM2 DCC ALMS1 GNAO1 CDH8	2.17e-03	443	152	8	EFO_0007876
Disease	Gastrointestinal Stromal Tumors	NDST1 TMEM231 SDHB	2.20e-03	50	152	3	C0238198
Disease	skin melanoma (is_implicated_in)	DDR1 BRCA2	2.30e-03	14	152	2	DOID:8923 (is_implicated_in)
Disease	unipolar depression, mood disorder, response to antidepressant	SLC4A8 CDH8	2.30e-03	14	152	2	EFO_0003761, EFO_0004247, GO_0036276
Disease	level of Phosphatidylcholine (18:1_18:2) in blood serum	BEST1 DOCK7	2.30e-03	14	152	2	OBA_2045100
Disease	Birth Weight	ADCY5 CDKAL1	2.30e-03	14	152	2	C0005612
Disease	Hereditary Breast and Ovarian Cancer Syndrome	RAD51 BRCA2	2.30e-03	14	152	2	C0677776
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	NEK10 BRCA2 GNAO1	2.46e-03	52	152	3	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	testosterone measurement	DDR1 ZNF536 ARHGAP10 TRPM2 NTNG1 EYA1 KAT2B MGAT5 UGT2A1 UGT2B4 UGT2B10 MACF1 FAM47E TPPP3 UGT2B11	2.50e-03	1275	152	15	EFO_0004908
Disease	Ciliopathies	WDR19 GUCY2D TMEM231 TOPORS	2.56e-03	110	152	4	C4277690
Disease	metabolite measurement	ABCC4 CYP2D6 ACADS DCC CDKAL1 ALMS1 UGT2B4 UGT2B10 UGT2B11	2.56e-03	560	152	9	EFO_0004725
Disease	Body Weight	CDKAL1 GNPDA2	2.65e-03	15	152	2	C0005910
Disease	Non-steroidal anti-inflammatory and antirheumatic product use measurement	NDST1 GNAO1	2.65e-03	15	152	2	EFO_0009935
Disease	Metastatic melanoma	NEK10 GUCY2D ALPK2	2.74e-03	54	152	3	C0278883
Disease	pneumonia, COVID-19	MAP2 MELK WDR19 HSP90AA4P	2.82e-03	113	152	4	EFO_0003106, MONDO_0100096
Disease	longevity	ABCC4 NTHL1 EYA1 DCC CSE1L BMPER	3.63e-03	284	152	6	EFO_0004300
Disease	basophil measurement	NDST1 RASGEF1A PSMD2	3.70e-03	60	152	3	EFO_0803539
Disease	Alzheimer disease	BIN1 ZSCAN12 SLC4A8 SASH1 FAM47E BMPER SIPA1L2 HSP90AA4P	3.76e-03	485	152	8	MONDO_0004975
Disease	phosphatidylcholine 36:4 measurement	UGT2B4 UGT2B11	3.82e-03	18	152	2	EFO_0010382
Disease	disease progression measurement	ADCY5 UGT2B4 UGT2B11	3.88e-03	61	152	3	EFO_0008336
Disease	cortical surface area change measurement, age at assessment	ZNF536 BMPER	4.26e-03	19	152	2	EFO_0008007, EFO_0021503
Disease	serum IgE measurement	GNAO1 SIPA1L2 IL4R	4.44e-03	64	152	3	EFO_0004579
Disease	word reading	DOCK7 CDH8 NOS1AP	4.63e-03	65	152	3	EFO_0005300
Disease	level of Phosphatidylcholine (16:0_18:2) in blood serum	BEST1 DOCK7	4.71e-03	20	152	2	OBA_2045071
Disease	mean corpuscular hemoglobin concentration	RBL1 PSMD2 HNRNPUL1 NDUFS2 CDKAL1 PPM1B KAT2B CCBE1 UGT2B10 ABCB11 FAM227A MACF1 FAM47E	4.81e-03	1105	152	13	EFO_0004528

Protein segments in the cluster

Peptide	Gene	Start	Entry
KKSNHQEFEALAMPE	TTF1	281	Q15361
IDPKAADTKKANHMF	FAM227A	516	F5H4B4
ADFVKSHQKPPQGME	PGM3	251	O95394
MILNEPFKSEVHKGN	CHD5	1766	Q8TDI0
PLAMSDVGKVHKKDN	CRYBG3	1516	Q68DQ2
DKEHLFPAAQVKKMG	ACADS	61	P16219
KIQAEMFPEHSGNVK	ALPK2	1791	Q86TB3
LKKQPSHMEAAHFGD	AKAP10	91	O43572
PTKKNRMQLSDDEGH	BHLHE40	286	O14503
KFSDVHPVALNFMKG	CDKL4	251	Q5MAI5
ASGDADMKGHFDPAK	DDR1	16	Q08345
AKQDPEEEKMHFHNG	EPHA5	626	P54756
SKAPGVDDQMNKHHF	ALMS1	2971	Q8TCU4
NHPMDAEVTKAKLLG	AP2A1	896	O95782
DPDQGKVMIDGHDSK	ABCB11	1131	O95342
MDHGVDSSIFQNPKK	ASCC1	191	Q8N9N2
GFMTPAEHKQLEKLS	BEST1	161	O76090
FLMDHQKDVFKIPGT	DEPDC7	411	Q96QD5
EKNLPKMAEALAHGA	ACAP2	616	Q15057
MGFEDPKDKNAQESA	ADCY5	696	O95622
PLHAKMDESKEGSIQ	CCDC180	721	Q9P1Z9
PKKLSVEEFFMDLHN	DIAPH1	1126	O60610
PHSFKIGEEAEEMKK	CCDC140	131	Q96MF4
AAAEHKGKIIMHDPF	PCK1	466	P35558
AQVDGAAMFAADPKK	RAD51	271	Q06609
MQAPPGHDQDSLKKS	GOPC	266	Q9HD26
NQAHMEETPKRKGAK	MELK	511	Q14680
DPNIQDKSGKTALMH	ANKRD34B	76	A5PLL1
AAKKFNMIPFEHRSG	ARHGAP10	296	A1A4S6
ADTKANKPGMNLLHF	FHDC1	326	Q9C0D6
TLKVEHPDKMANDQG	DCC	1041	P43146
KEEHGEAHMAPLFEK	LNP1	161	A1A4G5
LPGEYNEHTKKQMET	NMBR	246	P28336
HDKGMTVQPELKASF	NIPAL3	346	Q6P499
VHDAKMTPEDYEKLG	NMRAL1	236	Q9HBL8
LEANPGEKRKMTDSH	KAT2B	421	Q92831
EPSFFQHLNKDKDML	MGAT5	661	Q09328
PSMDHTFDLFKNINK	GUCY2D	796	Q02846
ALAMKFKTTHAPPGD	KCNH7	756	Q9NS40
QPDKDSAHKEGAMTV	LRRC53	1176	A6NM62
EHPAAQKEKSMDQDF	JCAD	1331	Q9P266
FASPSKHPMDSKGEE	KIAA0930	141	Q6ICG6
AMKEVNLHNPAFGKD	NEK10	546	Q6ZWH5
IVPKMASDFLHGNKS	OR2L8	76	Q8NGY9
EADAAIAKHMKHPQG	PPL	86	O60437
PDVKKNSHFSDFMDK	PDE6C	156	P51160
DGVEEEQGAKKHAMP	EYA1	556	Q99502
IKDSDKMLSFRAHGP	DLG5	811	Q8TDM6
LNKKFAVEHGIPTDM	NDST1	411	P52848
DGKHQDLKYISPETM	CDC25B	406	P30305
FVKESHNMSKGPEAT	LAMP5	121	Q9UJQ1
PGDNALDMFQKHREK	ALOX12	116	P18054
IIKFSMPGDQIKDFH	PARP4	561	Q9UKK3
KMNSGAKHVLDALDP	LIG3	421	P49916
VKKPKHMSADDLNDG	NOP14	306	P78316
TNVQKPDKHEGFMLK	OSBPL6	81	Q9BZF3
DPDKEYNMPKDGTVH	EXOC7	486	Q9UPT5
NKKAAGIDPMEQPHS	MAS1L	346	P35410
LRHADNMPKKSADDF	NCKAP1	386	Q9Y2A7
NMPKKSADDFIDKHI	NCKAP1	391	Q9Y2A7
SEKELENMHKGGSSP	MACF1	3901	Q9UPN3
APGFAHLAGLDKMSK	NDUFS2	426	O75306
MKSDNHSFLGDSPKA	OR2B11	1	Q5JQS5
QLPSDGKKMVHVQDF	ABCC4	401	O15439
PELMHAVKEVFKAAA	IDH3B	61	O43837
DEDPHKAAKEMPFQG	IL4R	321	P24394
AVNKMDLPDAQDKFH	GTPBP10	276	A4D1E9
DGDSFVEVMAAPHLK	BMPER	476	Q8N8U9
DFSKHPQEEKMFSPT	CPZ	391	Q66K79
NDGHNPLMKKVFDIH	DOCK11	1426	Q5JSL3
ELAFATHQDPADPKM	DOCK7	2006	Q96N67
ADHGHNPLMKKVFDV	DOCK9	1421	Q9BZ29
SGHMTDPNFKKETEA	BRCA2	521	P51587
IHKDGNDFKEPYQEM	DNAH3	466	Q8TD57
ESGKHFMKGQPVSDA	CDKAL1	481	Q5VV42
LAEMEKAKGNPESSF	CYP2D6	276	P10635
SQTPAPEHDKAANKM	CRACD	941	Q6ZU35
PNDTGHEKSENMVKA	CCBE1	181	Q6UXH8
DEKGPVMSKTHDHQL	DSN1	11	Q9H410
IEAGAHMDATNAFKK	FEM1A	601	Q9BSK4
AKENHTPEMKHFVGL	CEP162	1301	Q5TB80
NLGKEDEDKSFDMPH	DRC7	401	Q8IY82
VHNKLVDPLFSMKDG	GNPDA2	261	Q8TDQ7
KGTRHSDMFLLKPED	KLHDC4	261	Q8TBB5
SMVVEHPEFLKAGKE	GSN	51	P06396
GYMAAKKHLEINPDH	HSP90AA1	626	P07900
MAAKKHLEINPDHSF	HSP90AA4P	316	Q58FG1
TVSAMDKDDPKNGHY	CDH8	516	P55286
MPSKTKYNLVDDGHD	NOS1AP	1	O75052
AGLEENFHKEMSKLN	BIN1	246	O00499
KNVMPLSAGLFKSEH	RYR2	1561	Q92736
GPHGDKDKMVAVASE	KCTD3	241	Q9Y597
MKPEFEKAAEALHGE	PDIA5	311	Q14554
KDVPDHAVLEMKANF	HNRNPUL1	551	Q9BUJ2
KNSLQYSAKEHGMPE	PHF20L1	901	A8MW92
DCLDAFHMDPKSVKD	NTNG1	181	Q9Y2I2
YEEKPHKMDLLHENG	FAM47E	201	Q6ZV65
ENKAKSHLHMEAPFE	RGSL1	321	A5PLK6
NKKMQEPSAHTFDDA	RGS19	166	P49795
ENPDEAEKALKHMDG	RNPS1	211	Q15287
PAAVGAMEDKSAEHK	TES	216	Q9UGI8
EEKTAAEQFKFHMPD	SKA2	106	Q8WVK7
SDGDKKPMVDAQHFL	TMEM131L	1331	A2VDJ0
MFEDKPHAEGAAVVA	RBL1	1	P28749
PHMEDGKLVKNNAST	RPL3L	291	Q92901
DKDKKEAPADMGAHQ	PSMD2	636	Q13200
AMRNKKDAPVDHLGT	NTHL1	101	P78549
KQMKIIHEDGFSGED	GNAO1	51	P09471
VGPSSDKALTFMKDH	SEMA4A	381	Q9H3S1
DNGLKPDHMQRLTFK	PIWIL4	791	Q7Z3Z4
VINDKHDDVMAKFGA	PSMD1	716	Q99460
MSDPRQSQEEKHKLG	SIPA1L2	1	Q9P2F8
DHLLGENDGMPKDAK	WDR19	1076	Q8NEZ3
MGAFLDKPKTEKHNA	PPM1B	1	O75688
VDLHFMKKIPTGAEA	SLC4A8	286	Q2Y0W8
VYEMESHAIGKKPEN	SNAPC3	156	Q92966
SHAIGKKPENSADMI	SNAPC3	161	Q92966
GFNFRKMPEKDLHEG	SERPINA12	101	Q8IW75
RDKFMHKDGSVPLAA	SLC25A13	416	Q9UJS0
MAADKPADQGAEKHE	CNOT10	1	Q9H9A5
KELFGAGMKPIHAAD	CNOT6L	336	Q96LI5
LPAHMDKAEQRKDNF	INPP5J	561	Q15735
NDHQKMEGFHIKSPK	XIRP2	1956	A4UGR9
EMLKQAVKDHNVGSP	UHRF1BP1L	401	A0JNW5
AVSKPDMISHLENGK	ZNF624	96	Q9P2J8
LAFAGKKEHDPVGQM	CSE1L	906	P55060
AEHFKMPEAGEGKSQ	XAGE2	96	Q96GT9
KTAKFDVLEHHMDPS	RASGEF1A	336	Q8N9B8
FADQPDNIAHMKAKG	UGT2B4	396	P06133
AMKELSEAAEAQHGP	STX11	106	O75558
KKHVQEMPTDAFGDI	TRPM2	116	O94759
MAQKHSVPIGDVAKD	SLC6A3	371	Q01959
MKKPSTEGGEEHVFE	SASH1	281	O94885
HPLSAADFGKIMKNV	RFX7	46	Q2KHR2
FFDQPDNIAHMKAKG	UGT2B11	396	O75310
PMHKNGDKEFQTGKE	MAP2	611	P11137
KFAIHGDPKASGQEM	TPPP3	16	Q9BW30
LHFEKPAKPANMGQD	nan	276	Q3C1V9
ADGSKQKMPADLVHS	ZNF536	571	O15090
DGEINYKEGPMTHKN	ZNF841	31	Q6ZN19
NSVHKPERGSADMKL	ZCCHC14	511	Q8WYQ9
DPLDDNRMGKKHDKS	ZBED6	221	P86452
QDGKTDMLHFKLELP	TMEM231	111	Q9H6L2
AAKEFKMDNFSPKAG	TOPORS	71	Q9NS56
FDQPDNIAHMKAKGA	UGT2B10	396	P36537
EKGMEGKTPLDLFAH	ZNF687	151	Q8N1G0
KLFDTQHRVEKMPDG	TRMT12	41	Q53H54
VPQKTAGKENHFDMH	ZNF75A	106	Q96N20
KDPGFEQFKMSERLH	PIGG	371	Q5H8A4
KAGDKPHMQTYEVDL	SDHB	51	P21912
DQPDNIAHMKAKGAA	UGT2A1	396	P0DTE4
LHFVKESKQDESGMP	TRBV14	66	A0A5B0
EEMEPHGKTSSKFEN	ZSCAN12	201	O43309
MNHPFGKEEAASQKQ	ZFYVE26	1	Q68DK2
PGAQHSAMPAKSKEE	TMEM38A	271	Q9H6F2
HTGKKKPEISFMFQD	UFL1	466	O94874
FNLAETAHMPSKVKA	TMEM260	601	Q9NX78
EASAQRSHMGKLKEP	UNQ9165/PRO28630	111	Q6UXU0
FKEEAEMLKGLQHPN	WNK3	191	Q9BYP7
ADGFVKALDDLHKMN	JUNB	136	P17275
SQPDEDKMKEDTFAH	MXRA5	986	Q9NR99